Browsing Category

Top Industry News

7236 posts

Sanofi To Invest $1.05 Bn in New Insulin Mfg Base in China 
By

By
Sanofi has signed a memorandum of cooperation with the Beijing Municipal Bureau of Economy and Information Technology and the Beijing Economic and Technological Development Zone to establish a new EUR…

Amgen Investing $1 Bn in New Drug-Substance Mfg Facility 
By

By
Amgen has announced a $1-billion expansion to establish a second drug substance manufacturing facility in Holly Springs, North Carolina. This brings the company’s total planned investment in Holly Springs to…

Roche To Acquire Poseida Therapeutics in $1.5-Bn Deal 
By

By
Roche has agreed to acquire Poseida Therapeutics, a San Diego, California-based clinical-stage cell- and gene-therapy company developing treatments for cancer, autoimmune, and rare diseases, in a $1.5-billion deal ($1.0 billion…

Supplier News: Resilience, Cambrex, Agilent & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Resilience, Sartorius, Agilent, Cambrex, Evotec, Hovione and Samabriva.   Biologics Manufacturing * Resilience Names New CEO * Sartorius Opens New Center for Bioprocess Innovation * Samabriva…

Global Briefs: Novo Nordisk, Coherus & More 
By

By
A roundup of news from Novo Nordisk, Novavax, Coherus BioSciences and Intas Pharmaceuticals. Highlights below.   General * Novo Nordisk Investing $411 M in New Quality Control Facility Mfg News * Novo Nordisk To…

Packaging Companies Amcor, Berry Global To Merge in $8.4-Billion Deal 
By

By
Amcor, a Zurich, Switzerland-based provider of packaging for the pharmaceutical, food, beverage, and other markets, has agreed to acquire Berry Global, an Evansville, Indiana-based provider of packaging for various markets,…

Grifols Turns Down $6.8-Bn Takeover Offer 
By

By
Grifols, a Barcelona, Spain-headquartered healthcare company and manufacturer of plasma-derived medicines, has turned down a potential offer of EUR 6.45 billion ($6.76 billion) by Brookfield, a Toronto, Canada-based private equity…

Novartis Acquires Gene-Therapy Company Kate Therapeutics in $1.1-Bn Deal
By

By
Novartis has acquired Kate Therapeutics, a San Diego, California-based gene-therapy company specializing in treating genetically defined neuromuscular diseases, in a $1.1-billion deal (undisclosed upfront payment and additional milestone payments). Kate…

Supplier News: Samsung Biologic, Fujifilm Diosynth, Evotec & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Samsung Biologics, Fujifilm Diosynth Biotechnologies, Vetter, Pii, and Evotec.   Biologics Manufacturing * Samsung Biologics Signs $668-M Contract Mfg Deal* Fujifilm Diosynth Biotechnologies Completes…

Mfg News: Sanofi, Orano Med & Endo 
By

By
A roundup of manufacturing news from Sanofi, Orano Med, and Endo. Highlights below  * Sanofi Investing $42 M To Expand Bioproduction in France* Orano Med Investing $262 M To Expand…